This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sequent Scientific's Joint Managing Director Resigns MT
Sequent Scientific Limited Announces Resignation of Sharat Pandurang Narasapur, Jt. Managing Director, from the Board of Directors, Member of the Corporate Social Responsibility Committee of the Board Effective on April 30, 2024 CI
Transcript : Sequent Scientific Limited, Q3 2024 Earnings Call, Feb 15, 2024
Sequent Scientific Limited Announces Executive Changes CI
Sequent Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Sequent Scientific Limited Announces Resignation of Krunal Shah as Company Secretary & Compliance Officer, Effective on February 15, 2024 CI
Sequent Scientific Appoints CFO MT
Transcript : Sequent Scientific Limited, Q2 2024 Earnings Call, Nov 07, 2023
Sequent Scientific's CFO Resigns MT
Sequent Scientific Limited Announces Patri Venkat Raghavendra Rao as Chief Financial Officer CI
Transcript : Sequent Scientific Limited, Q1 2024 Earnings Call, Aug 11, 2023
Sequent Scientific Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Sequent Scientific Discontinues Manufacturing Operations at Tarapur Unit in India MT
Sequent Scientific Limited Announces Discontinuation of Manufacturing Operations At Tarapur, Maharashtra CI
Transcript : Sequent Scientific Limited, Q4 2023 Earnings Call, May 24, 2023
Sequent Scientific Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
INDIA STOCKS-Indian shares fall on rate fears after Powell reiterates hawkish message RE
SeQuent Scientific Terminates Agreement to Acquire Tineta Pharma MT
Indian shares set for muted start as Powell reiterates hawkish message RE
Sequent Scientific Limited cancelled the acquisition of Tineta Pharma Private Limited from group of shareholders. CI
Transcript : Sequent Scientific Limited, Q3 2023 Earnings Call, Feb 15, 2023
Sequent Scientific Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Sequent Scientific Limited Announces Resignation of Rahul Mukim as Director CI
Transcript : Sequent Scientific Limited, Q2 2023 Earnings Call, Nov 08, 2022
Sequent Scientific Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Chart Sequent Scientific Limited
More charts
SeQuent Scientific Limited is an India-based animal health company. The Company provides a wide range of animal health products, including finished dose formulations, active pharmaceutical ingredients (APIs), as well as analytical services. The Company operates through the pharmaceuticals segment. The Company is focused on various therapies, such as targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infectives and dermatology. It is specialized in analytical and bio analytical services to support the API, pharmaceutical, personal care and nutraceutical companies. It provides analytical solutions, including method validation, stability, microbiology for APIs and finished products in a variety of dosage forms as per pharmacopoeia monographs, customer developed methods or in-house method development. Its subsidiaries include Alivira Animal Health Limited and SeQuent Research Limited.
Calendar
More about the company

Quarterly revenue - Rate of surprise